miR-141-3p、KLF9异常表达对前列腺癌细胞株药物敏感性和雄激素受体表达的影响及靶向关系OACSTPCD
Effects of abnormal expression of miR-141-3p and KLF9 on drug sensitivity and androgen receptor expression of prostate cancer cells and the targeting relationship
目的 观察miR-141-3p、Krüppel样因子9(KLF9)对前列腺癌细胞株药物敏感性、雄激素受体(AR)表达的影响,验证miR-141-3p、KLF9之间的靶向关系,以探讨miR-141-3p、KLF9对PCa药物敏感性的调控作用及机制.方法 选择雄激素敏感且表达AR的LNCaP细胞株.将细胞分为miR-141-3p低表达组、miR-141-3p正常组、KLF9过表达组、KLF9正常组,采用脂质体转染法分别转染miR-141-3p-inhibitor、inhibitor阴性对照物(inhibitor-NC)、KLF9过表达质粒、空白质粒.上述各组细胞加入不同浓度(0、10、25、50、75、100 μmol/L)比卡鲁胺或(0.5、1.0、2.5、5.0 nmol/L)多西他赛后培养48 h,检测各组细胞OD值,计算细胞增殖率(反映药物敏感性).采用qRT-PCR和Western blotting法检测各组细胞中AR及AR-V7.采用TargetScan数据库预测miR-141-3p与KLF9是否存在结合位点,然后采用荧光素酶报告基因实验验证miR-141-3p与KLF9的靶向调控关系[将LNCaP细胞株分别分为A、B、C、D组,A组先后转染野生型KLF9 荧光素酶报告基因质粒(KLF9-WT)、inhibitor-NC,B组先后转染KLF9-WT、miR-141-3p-inhibitor,C组先后转染突变型KLF9荧光素酶报告基因质粒(KLF9-Mut)、inhibitor-NC,D组先后转染KLF9-Mut、miR-141-3p-in-hibitor,转染24 h后检测各组荧光素酶活性].通过细胞功能回复实验进一步验证miR-141-3p通过靶向调控KLF9抑制前列腺癌细胞药物敏感性[将LNCaP细胞株分别分为a、b、c、d组,a组先后转染si-KLF9阴性对照(si-Ctrl)、inhibitor-NC,b组先后转染si-Ctrl、miR-141-3p-inhibitor,c组先后转染si-KLF9、inhibitor-NC,d组先后转染si-KLF9、miR-141-3p-inhibitor,转染24 h后分别使用75 μmol/L比卡鲁胺或2.5 nmol/L多西他赛处理细胞48 h,使用CCK-8法检测细胞OD值,并计算细胞增殖率].结果 LNCaP细胞培养48 h,在无药物加入时,miR-141-3p低表达组细胞增殖率低于miR-141-3p正常组(P均<0.05),KLF9过表达组细胞增殖率低于KLF9正常组(P均<0.05);随着药物浓度升高,各组细胞增殖率呈下降趋势(P均<0.05);在同等药物浓度情况下,miR-141-3p低表达组细胞增殖率低于miR-141-3p正常组(P均<0.05),KLF9过表达组细胞增殖率低于KLF9正常组(P均<0.05).LNCaP细胞培养48 h,与不加入药物的miR-141-3p正常组相比,加入75、100 μmol/L比卡鲁胺的miR-141-3p正常组AR相对表达量升高(P均<0.05),加入50、75、100 μmol/L比卡鲁胺的miR-141-3p正常组AR-V7相对表达量升高(P均<0.05);加入0.5、1.0、2.5、5.0 nmol/L多西他赛的miR-141-3p正常组AR及AR-V7相对表达量升高(P均<0.05).miR-141-3p低表达组的AR及AR-V7相对表达量低于加入同药物浓度的miR-141-3p正常组(P均<0.05),KLF9过表达组的AR及AR-V7相对表达量低于加入同药物浓度的KLF9正常组(P均<0.05).TargetScan数据库预测miR-141-3p与KLF9存在结合位点,双荧光素酶报告实验显示,B组的相对荧光活性高于A组、C组及D组(P均<0.05).功能回复实验结果显示,d组的细胞增殖率高于b组(P均<0.05),低于c组(P均<0.05),但与a组差异无统计学意义(P>0.05).结论 miR-141-3p低表达、KLF9过表达均可增强LNCaP细胞株的药物敏感性,并可抑制LNCaP细胞株AR和AR-V7的表达,miR-141-3p和KLF9存在靶向关系,miR-141-3p可靶向KLF9抑制LNCaP细胞药物敏感性,可能是通过促进AR-V7的表达实现的.
Objective To observe the effects of microRNA-141-3p(miR-141-3p)and Krüppel-like factor 9(KLF9)on the drug sensitivity and androgen receptor(AR)expression of prostate cancer(PCa)cells,and to verify the targeting relationship between miR-141-3p and KLF9 in order to explore the regulatory effects and mechanism of miR-141-3p and KLF9 on the drug sensitivity of PCa cells.Methods Androgen-sensitive LNCaP cell line with AR expression was selected for this study.The cells were divided into low miR-141-3p expression group,normal miR-141-3p group,KLF9 overexpression group,and normal KLF9 expression group,respectively,which were transfected with the miR-141-3p-in-hibitor,inhibitor-negative control(NC)group,KLF9 overexpression plasmid,and empty plasmid,respectively,using li-posome transfection method.The cells were treated with different concentrations of bicalutamide(0,10,25,50,75,and 100 μmol/L)or docetaxel(0,0.2,0.5,1.0,2.5,and 5.0 nmol/L).After 48 h of culture,cell OD value was detected by CCK-8,and cell proliferation rate was calculated to evaluate drug sensitivity.The expression of AR and AR-V7 of LN-CaP cells was analyzed by qRT-PCR and Western blotting.TargetScan database was used to predict binding sites between miR-141-3p and KLF9.Then,the luciferase reporter gene experiment was used to verify the targeted regulatory relation-ship between miR-141-3p and KLF9.LNCaP cells were divided into groups A,B,C and D.Cells in the group A were transfected with wild-type KLF9 luciferase reporter gene plasmid(KLF9-WT)and inhibitor-NC;cells in the group B were transfected with KLF9-WT and miR-141-3p-inhibitor;cells in the group C were transfected with mutant KLF9 luciferase re-porter gene plasmid(KLF9-Mut)and inhibitor-NC;cells in the group D were transfected with KLF9-Mut and miR-141-3p-inhibitor.The relative luciferase activity of cells in each group was detected by dual luciferase reporter gene assay at 24 h after transfection.The inhibitory effect of miR-141-3p targetedly regulating KLF9 on the drug sensitivity of LNCaP cell was further examined by the rescue experiment.LNCaP cells were divided into groups a,b,c and d.Cells in the group a were transfected with si-KLF9 negative control(si-Ctrl)and inhibitor-NC;cells in the group b were transfected with si-Ctrl and miR-141-3p-inhibitor;cells in the group c were transfected with si-KLF9 and inhibitor-NC;cells in the group d were trans-fected with si-KLF9 and miR-141-3p-inhibitor.After transfection for 24 h,the cells were treated with 75 μmol/L bicaluta-mide or 2.5 nmol/L docetaxel for 48 h,respectively.The OD value of the cells was detected by CCK-8,and the cell prolif-eration rate was calculated.Results LNCaP cells were cultured for 48 h.When no drug was added,the cell prolifera-tion rate of the low miR-141-3p expression group was lower than that of the normal miR-141-3p expression group(P<0.05),and the cell proliferation rate of the KLF9 overexpression group was lower than that of the normal KLF9 expression group(P<0.05).With the increase of bicalutamide or docetaxel concentrations,the cell proliferation rates decreased(all P<0.05).Under the same drug concentration,the cell proliferation rate of the low miR-141-3p expression group was lower than that of the normal miR-141-3p expression group(P<0.05),and the cell proliferation rate of the KLF9 overexpression group was lower than that of the normal KLF9 expression group(P<0.05).The LNCaP cells were cultured for 48 hours.Compared with the normal miR-141-3p expression group without adding the drug,the relative expression levels of AR in-creased in the normal miR-141-3p expression groups added with 75 and 100 μmol/L bicalutamide(both P<0.05),and the relative expression levels of AR-V7 increased in the normal miR-141-3p groups added with 50,75,and 100 μmol/L bicalutamide(all P<0.05);the relative expression levels of AR and AR-V7 increased in the normal miR-141-3p groups added with 0.5,1.0,2.5,and 5.0 nmol/L docetaxel(all P<0.05).The relative expression levels of AR and AR-V7 in the low miR-141-3p expression group were lower than those in the normal miR-141-3p expression group added with the same drug concentration(both P<0.05),and the relative expression levels of AR and AR-V7 in the KLF9 overexpression group were lower than those in the normal KLF9 expression group added with the same drug concentration(both P<0.05).TargetScan database predicted the existence of binding sites between miR-141-3p and KLF9.Dual luciferase report experi-ment showed that the relative fluorescence activity was significantly higher in the group B than in the groups A,C and D(all P<0.05).Further rescue experiments showed that the cell proliferation rate of group d was significantly higher than that of the group b(P<0.05),and was significantly lower than that of the group c(P<0.05),but there was no significant difference between group d and group a(P>0.05).Conclusions Low expression of miR-141-3p or overexpression of KLF9 can enhance the drug sensitivity and inhibit the expression of AR and AR-V7 in LNCaP cells.MiR-141-3p and KLF9 have a targeted relationship.The inhibitory effect of miR-141-3p targeting KLF9 on drug sensitivity of LNCaP cells may be achieved by promoting the expression of AR-V7.
刘彼得;靳宏勇;王书恒;李循;李九智
新疆维吾尔自治区人民医院泌尿中心,乌鲁木齐 830001||新疆维吾尔自治区人民医院泌尿外科研究室
临床医学
微小RNA-141-3pKrüppel样因子药物敏感性比卡鲁胺多西他赛能雄激素受体雄激素受体剪接变异体7前列腺癌
microRNA-141-3pKrüppel-like factor 9drug susceptibilitybicalutamidedocetaxelandrogen receptorandrogen receptor splice variant 7prostate cancer
《山东医药》 2024 (015)
1-8 / 8
新疆维吾尔自治区科学技术厅自治区自然科学基金项目(2020D01C121);新疆维吾尔自治区人民医院院内科研项目(20190110).
评论